Compare AAL & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AAL | CRL |
|---|---|---|
| Founded | 1930 | 1947 |
| Country | United States | United States |
| Employees | 133700 | N/A |
| Industry | Air Freight/Delivery Services | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.6B | 7.5B |
| IPO Year | 2004 | 1999 |
| Metric | AAL | CRL |
|---|---|---|
| Price | $12.22 | $181.33 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 12 |
| Target Price | $15.84 | ★ $198.27 |
| AVG Volume (30 Days) | ★ 51.4M | 730.9K |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.17 | N/A |
| Revenue | ★ $54,633,000,000.00 | $1,857,601,000.00 |
| Revenue This Year | $11.42 | $0.19 |
| Revenue Next Year | $4.96 | $2.98 |
| P/E Ratio | $71.38 | ★ N/A |
| Revenue Growth | 0.78 | ★ 10.48 |
| 52 Week Low | $8.96 | $99.80 |
| 52 Week High | $16.50 | $228.88 |
| Indicator | AAL | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 61.04 | 61.88 |
| Support Level | $10.99 | $147.06 |
| Resistance Level | $13.94 | $182.76 |
| Average True Range (ATR) | 0.40 | 6.84 |
| MACD | 0.26 | 2.23 |
| Stochastic Oscillator | 90.53 | 89.67 |
American Airlines is the world's largest airline by aircraft, capacity, and scheduled revenue passenger miles. Its major US hubs are Dallas/Fort Worth, Charlotte, Chicago, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C. It generates over 30% of US airline revenue connecting Latin America with destinations in the United States. After completing a major fleet renewal, the company has the youngest average fleet of US legacy carriers.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.